Expression of insulin-like growth factor-II and leukemia inhibitory factor antibody immunostaining on the ionized calcium-binding adaptor molecule 1-positive microglias in the spinal cord of amyotrophic lateral sclerosis patients

Neuropathology

Volumn 27, Issue 3, 2007, Pages 257-268

  Kihira, Tameko ^a   Suzuki, Ai ^a   Kubo, Tomomi ^a   Miwa, Hideto ^a   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Insulin like growth factor I; Insulin like growth factor II; Leukemia inhibitory factor antibody; Microglia

Indexed keywords

ADAPTOR PROTEIN; ANTIBODY; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOTONEURON; MOTOR NEURON DISEASE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SPINAL CORD;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA INHIBITORY FACTOR; MALE; MICROGLIA; MIDDLE AGED; PROTEINS; SPINAL CORD;

EID: 34248998071     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00776.x     Document Type: Article

References (44)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001 344 : 1688 1700.
2. Sargsyan SA, Monk PN, Show PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005 4 : 241 53.
3. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999 57 : 563 81.
4. Kempermann G, Neumann H. Microglia: the enemy within? Science 2003 302 : 1689 90.
5. Tortarolo M, Veglianese P, Calvaresi N et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003 23 : 180 92.
6. Yoshihara T, Ishigaki S, Yamamoto M et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002 80 : 158 67.
7. Yosojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 2001 57 : 952 6.
8. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 1990 47 : 1210 16.
9. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992 140 : 691 707.
10. Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998 23 : 249 56.
11. Alexianu ME, Lozovska M, Appel SH. Immune reactivity in the mouse model of familial ALS correlates with disease progression. Neurology 2001 57 : 1282 9.
12. Hensley K, Fedynyshyn J, Ferrell S et al. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis 2003 14 : 74 80.
13. Graeber MB, Streit WJ, Kreutzberg GW. Formation of microglia-derived brain macrophages is blocked by adriamycin. Acta Neuropathol (Berl) 1989 78 : 348 58.
14. Tikka TM, Vartiainen NE, Goldsteins G et al. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neuron disease. Brain 2002 125 : 722 31.
15. Zhu S, Stavrovskaya IG, Drozda M et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002 417 : 74 8.
16. Weiss MD, Weydt P, Carter GT. Current pharmacological management of amyotrophic lateral sclerosis and a role for rational polypharmacy. Expert Opin Pharmacother 2004 4 : 735 46.
17. Polazzi E, Contestabile A. Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 2002 13 : 21 42.
18. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005 18 : 315 21.
19. Suzuki T, Izumi H, Ido K, Kohsaka S, Inoue K, Nakata Y. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 2004 24 : 1 7.
20. Taylor DL, Diemel LT, Pocock JM. Activation of microglia group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci 2003 23 : 2150 60.
21. Mori I, Goshima F, Koshizuka T et al. Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion. Mol Brain Res 2003 120 : 52 6.
22. Schnell SA, Staines WA, Wessendorf MW. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999 47 : 719 30.
23. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localization of a novel calcium binding protein, Iba1. Mol Brain Res 1998 57 : 1 9.
24. D'Costa AP, Prevette DM, Houenou LJ et al. Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons. J Neurobiol 1998 36 : 379 94.
25. Kerkhoff H, Hassan SM, Troost D, Van Etten RW, Veldman H, Jennekens FG. Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1994 87 : 411 21.
26. Roth GA, Spada V, Hamill K, Bornstein MB. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Brain Res Dev Brain Res 1955 88 : 102 08.
27. Pu SF, Zhuang HX, Marsh DJ, Ishii DN. Insulin-like growth factor-II increase and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy. J Neurosci Res 1999 55 : 9 16.
28. Festoff BW, Yang SX, Vaught J, Bryan C, Ma JY. The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies. J Neurol Sci 1995 129 (Suppl 114 21.
29. Vincent AM, Mobley BC, Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 2004 16 : 407 16.
30. Nagano I, Ilieva H, Shiote M et al. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis. J Neurol Sci 2005 235 : 61 8.
31. Kaspar BK, Llado J, Sherkat N, Rothstain JD, Gage FH. Retrograde viral delivery of IGF-I prolongs survival in a mouse ALS model. Science 2003 301 : 839 42.
32. Neff NT, Prevette D, Houenou LJ et al. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J Neurobiol 1993 24 : 1578 88.
33. Near SL, Whalen LR, Miller JA, Ishii DN. Insulin-like growth factor II stimulates motor nerve regeneration. Proc Natl Acad Sci USA 1992 89 : 11716 20.
34. Torres-Aleman I, Barrios V, Berciano J. The peripheral insulin-like growth factors system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 1998 50 : 772 6.
35. Dore S, Krieger C, Kar S, Quirion R. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients. Brain Res Mol Brain Res 1996 41 : 128 33.
36. Ono S, Hu J, Imai T, Shimizu N, Tsumura M, Nakagawa H. Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000 69 : 199 203.
37. Ikeda K, Iwasaki Y, Tagaya N, Shiojima T, Kinoshita M. Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor on wobbler murine motor neuron disease. Muscle Nerve 1995 18 : 1344 7.
38. Dowsing BJ, Romeo R, Morrison WA. Expression of leukemia inhibitory factor in human nerve following injury. J Neurotrauma 2001 18 : 1279 87.
39. Curtis R, Scherer SS, Somogyi R et al. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve. Neuron 1994 12 : 191 204.
40. Azari MF, Galle A, Lopes EC, Kurek J, Cheema SS. Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis. Brain Res 2001 922 : 144 7.
41. Feeney SL, Austin L, Bennett TM et al. The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis. Cytokine 2003 23 : 108 18.
42. Walicke PA. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J Neurosci 1988 8 : 2618 627.
43. Kuzis K, Coffin JD, Eckenstein FP. Time course and age dependence of motor neuron death following facial nerve crush injury: role of fibroblast growth factor. Exp Neurol 1999 157 : 77 87.
44. Johansson A, Larsson A, Nygren I, Blennow K, Askmark H. Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis. Neuroreport 2003 14 : 1867 1869.